From the beginning, the approval of its Aduhelm (aducanumab) treatment was met with controversy – over the interactions with the FDA, and the advisor committee’s vote against the treatment ...

Eisai and Biogen's Alzheimer's therapy Leqembi will be priced at $26,500 per year – a little less than misfired predecessor Aduhelm – after getting conditional authorisation for the drug from ...

A Boston College Center for Retirement Research report looks at the financial implications for Medicare of Alzheimer's drug Aduhelm The recent controversy over Alzheimer’s treatment Aduhelm—criticized ...

It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how repurposing GLP-1s and psychedelics for addiction treatment introduces unexpected patent challenges, ...

A nurse who was suspended by a Scottish health board after she objected to a transgender doctor using a women's changing room has called for action following the Supreme Court ruling on the legal ...

Repeated failures in mental health care have seen "avoidable deaths" continue in places people should be safe, an inquiry has heard. The Lampard Inquiry is analysing the deaths of more than 2,000 ...

Filled with the top stories to start your day, and emergency news alerts.

'Must exercise restraint': SC slams MP minister for 'irresponsible' remarks on Col. Sofiya Qureshi The Supreme Court reprimanded Madhya Pradesh minister Vijay Shah for his "irresponsible" remarks ...

Erik and Lyle, who have spent more than 30 years behind bars for the murder of their parents, are now eligible for parole. The 'Past Lives' filmmaker's sophomore feature starring Dakota Johnson is ...